Leslie Crews

12.3k total citations · 3 hit papers
90 papers, 8.8k citations indexed

About

Leslie Crews is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Leslie Crews has authored 90 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 27 papers in Physiology and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Leslie Crews's work include Alzheimer's disease research and treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (17 papers) and RNA regulation and disease (12 papers). Leslie Crews is often cited by papers focused on Alzheimer's disease research and treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (17 papers) and RNA regulation and disease (12 papers). Leslie Crews collaborates with scholars based in United States, Italy and Canada. Leslie Crews's co-authors include Eliezer Masliah, Edward Rockenstein, Anthony Adame, Christina Patrick, Makoto Hashimoto, Brian Spencer, Paula Desplats, Michael A. Lemp, Benjamin D. Sullivan and Seung‐Jae Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Leslie Crews

84 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

2009 1.2k citations Paula Desplats, He-Jin Lee et al. Proceedings of the National Academy of Sciences profile →
Molecular mechanisms of neurodegeneration in Alzheimer's disease

2010 574 citations Leslie Crews, Eliezer Masliah profile →
Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Patient Cohort

2012 422 citations Michael A. Lemp, Leslie Crews et al. profile →

Peers

Countries citing papers authored by Leslie Crews

Since Specialization

Citations

This map shows the geographic impact of Leslie Crews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Crews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Crews more than expected).

Fields of papers citing papers by Leslie Crews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Crews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Crews. The network helps show where Leslie Crews may publish in the future.

Co-authorship network of co-authors of Leslie Crews

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Crews. A scholar is included among the top collaborators of Leslie Crews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Crews. Leslie Crews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The proteostasis network is a therapeutic target in acute myeloid leukemia 2025 ·Blood ·Kentson Lam, (unknown), (unknown), (unknown), (unknown), Fanny Zhou, Mary Jean Sunshine, Bernadette A. Chua, (unknown), (unknown), (unknown), (unknown), Jiehua Zhou, Yuning Hong, Eric J. Bennett, Leslie Crews, Edward D. Ball, Robert Signer	0
2	Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development 2025 ·GeroScience ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hojun Li, Dorota Skowronska‐Krawczyk, Leslie Crews	0
3	The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma 2023 ·International Journal of Molecular Sciences ·Natalia Platonova, Elisa Lazzari, M. Colombo, Monica Falleni, Delfina Tosi, (unknown), Valentina Citro, Lavinia Casati, Domenica Ronchetti, Niccolò Bolli, Antonino Neri, Federica Torricelli, Leslie Crews, Catriona Jamieson, Raffaella Chiaramonte	1
4	Reversal of malignant ADAR1 splice isoform switching with Rebecsinib 2023 ·Cell stem cell ·Leslie Crews, Wenxue Ma, Luisa Ladel, Jessica Pham, Larisa Balaian, (unknown), (unknown), (unknown), Christina Wu, Cayla Mason, Inge van der Werf, Isabelle Oliver, Eduardo Reynoso, Gabriel Pineda, Thomas Whisenant, Peggy Wentworth, James J. La Clair, Qingfei Jiang, Michael D. Burkart, Catriona Jamieson	40
5	Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption 2021 ·Cell stem cell ·(unknown), (unknown), Tianyuan Zhou, Elisa Lazzari, Luisa Ladel, Xiaolin Luo, Youngsoo Kim, Caitlin Costello, A. Robert MacLeod, Catriona Jamieson, Leslie Crews	38
6	Sensitive intranuclear flow cytometric quantification of IRF4 protein in multiple myeloma and normal human hematopoietic cells 2021 ·STAR Protocols ·(unknown), (unknown), Caitlin Costello, A. Robert MacLeod, Leslie Crews	3
7	Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma 2017 ·Nature Communications ·Elisa Lazzari, (unknown), Nathaniel P. Delos Santos, Amber Miller, Gabriel Pineda, Qingfei Jiang, Heather Leu, (unknown), Anusha-Preethi Ganesan, Christina Wu, Caitlin Costello, Mark D. Minden, Raffaella Chiaramonte, A. Keith Stewart, Leslie Crews, Catriona Jamieson	87
8	RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML 2016 ·Cell stem cell ·Leslie Crews, Larisa Balaian, Nathaniel P. Delos Santos, Heather Leu, Angela C. Court, Elisa Lazzari, Anil Sadarangani, M Zipeto, James J. La Clair, Reymundo Villa, Anna Kulidjian, Rainer Storb, Sheldon Morris, Edward D. Ball, Michael D. Burkart, Catriona Jamieson	90
9	NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches 2012 ·PLoS ONE ·Wenxue Ma, Alejandro Gutiérrez, Daniel Goff, Ifat Geron, Anil Sadarangani, Christina Jamieson, Angela C. Court, Alice Shih, Qingfei Jiang, Christina Wu, Kang Li, Kristen M. Smith, Leslie Crews, Neil W. Gibson, Ida Deichaite, Sheldon Morris, Ping Wei, Dennis A. Carson, A. Thomas Look, (unknown), (unknown)	29
10	Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation 2012 ·FEBS Journal ·Igor F. Tsigelny, Yuriy Sharikov, Wolfgang Wrasidlo, Tania Gonzalez, Paula Desplats, Leslie Crews, Brian Spencer, Eliezer Masliah	139
11	Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications 2012 ·Acta Ophthalmologica ·Benjamin D. Sullivan, Leslie Crews, Elisabeth M. Messmer, Gary N. Foulks, Kelly K. Nichols, Philipp B. Baenninger, Gerd Geerling, Francisco C. Figueiredo, Michael A. Lemp	296
12	Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein breakdown → 2009 ·Proceedings of the National Academy of Sciences ·Paula Desplats, He-Jin Lee, Eun-Jin Bae, Christina Patrick, Edward Rockenstein, Leslie Crews, Brian Spencer, Eliezer Masliah, Seung‐Jae Lee	1156
13	Neuropeptide Y Fragments Derived from Neprilysin Processing Are Neuroprotective in a Transgenic Model of Alzheimer's Disease 2009 ·Journal of Neuroscience ·J. Bart Rose, Leslie Crews, Edward Rockenstein, Anthony Adame, Michael Mante, Louis B. Hersh, Fred H. Gage, Brian Spencer, Rewati Potkar, Robert A. Marr, Eliezer Masliah	78
14	Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice 2008 ·BMC Neuroscience ·Brian Spencer, Robert A. Marr, Edward Rockenstein, Leslie Crews, Anthony Adame, Rewati Potkar, Christina Patrick, Fred H. Gage, Inder M. Verma, Eliezer Masliah	71
15	Immunotherapy Strategies for Lewy Body and Parkinson's Diseases 2008 ·Leslie Crews, Brian Spencer, Eliezer Masliah	2
16	α-Synuclein Aggregates Interfere with Parkin Solubility and Distribution 2008 ·Journal of Biological Chemistry ·Kohichi Kawahara, Makoto Hashimoto, Pazit Bar‐On, Gilbert Ho, Leslie Crews, Hideya Mizuno, Edward Rockenstein, Syed Z. Imam, Eliezer Masliah	50
17	High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels 2005 ·Journal of Biological Chemistry ·Edward Rockenstein, Michael Mante, Michael Alford, Anthony Adame, Leslie Crews, Makoto Hashimoto, Luke Esposito, Lennart Mucke, Eliezer Masliah	85
18	Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer?s disease with the neurotrophic compound Cerebrolysin? 2004 ·Journal of Neural Transmission ·Edward Rockenstein, Anthony Adame, Michael Mante, (unknown), Leslie Crews, Manfred Windisch, Herbert Moessler, Eliezer Masliah	38
19	The Role of α-Synuclein Assembly and Metabolism in the Pathogenesis of Lewy Body Disease 2004 ·Journal of Molecular Neuroscience ·Makoto Hashimoto, Kohichi Kawahara, Pazit Bar‐On, Edward Rockenstein, Leslie Crews, Eliezer Masliah	40
20	Expression and activity of the newt Msx-1 gene in relation to limb regeneration 1995 ·Proceedings of the Royal Society B Biological Sciences ·Leslie Crews, Phillip B. Gates, Robert Brown, Alain Joliot, Carolyn J. Foley, Jeremy P. Brockes, Alexander Gann	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact